Repurposing radiosensitising medicines for radiotherapy: an overview
Repurposing established non-cancer drugs for the treatment of cancer offers potential benefits such as speed of clinical translation and financial efficiencies. In this study, we assess the landscape of repurposing drugs for combined use with radiotherapy (RT) based on their capacity to increase tum...
Saved in:
Main Authors: | Geoff S Higgins, Jie Man Low, Gonzalo Rodriguez-Berriguete |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | BMJ Oncology |
Online Access: | https://bmjoncology.bmj.com/content/3/1/e000192.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A review of bismuth‐based nanoparticles and their applications in radiosensitising and dose enhancement for cancer radiation therapy
by: Daryoush Shahbazi‐Gahrouei, et al.
Published: (2023-06-01) -
Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis
by: Bonnie Hei Man Liu, et al.
Published: (2025-02-01) -
Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis
by: EBENEZER OLUWAKEMI, et al.
Published: (2022-06-01) -
Drug repurposing screen for the rare disease ataxia-telangiectasia
by: Namrata Jayanth, et al.
Published: (2025-01-01) -
Editorial: Drug repurposing for cancer treatment: current and future directions
by: Marios Lampros, et al.
Published: (2025-02-01)